Clinical outcomes in metastatic renal cell carcinoma (mRCC) treated with combination of nivolumab and cabozantinib (nivo-cabo) in the salvage setting.

被引：1
|
作者：
Ravindranathan, Deepak
Liu, Yuan
Martini, Dylan J.
Nazha, Bassel
Brown, Jacqueline T.
Russler, Greta
Yantorni, Lauren Beth
Caulfield, Sarah
Master, Viraj A.
Carthon, Bradley Curtis
Kucuk, Omer
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA
[3] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA
[4] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16570
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Distinct outcomes in Hispanic/Latinx and non-Hispanic/Latinx patients with metastatic renal cell carcinoma (mRCC) treated with first-line ipilimumab plus nivolumab (ipi/nivo).
    Ali, Sana
    Leong, Sally
    Meza, Luis A.
    Dizman, Nazli
    Zengin, Zeynep Busra
    Kim, Tane
    Pak, Youngju
    Onyshchenko, Mykola
    Pal, Sumanta K.
    Chehrazi-Raffle, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Phase II trial of intermittent therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with front-line ipilimumab and nivolumab (Ipi/Nivo).
    George, Laeth
    Wei, Wei
    Diaz-Montero, C. Marcela
    Martin, Allison
    Vyas, Neil
    Basu, Arnab
    Beckermann, Katy
    Nizam, Amanda
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Gupta, Shilpa
    Rini, Brian I.
    Ornstein, Moshe Chaim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [43] Real world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Stukalin, Igor
    Wells, J. Connor
    Graham, Jeffrey
    Yuasa, Takeshi
    Beuselinck, Benoit
    Kollmannsberger, Christian K.
    Ernst, D. Scott
    Agarwal, Neeraj
    Le, Tri
    Donskov, Frede
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Srinivas, Sandy
    Wood, Lori
    Alva, Ajjai Shivaram
    Kanesvaran, Ravindran
    Fu, Simon Yuen Fai
    Davis, Ian D.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [44] Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C)
    Kline, Meredith R.
    Martini, Dylan J.
    Liu, Yuan
    Shabto, Julie M.
    Carthon, Bradley Curtis
    Hitron, Elise
    Russler, Greta
    Caulfield, Sarah
    Yantorni, Lauren Beth
    Harris, Wayne
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [45] Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Stukalin, I
    Wells, J. C.
    Graham, J.
    Yuasa, T.
    Beuselinck, B.
    Kollmansberger, C.
    Ernst, D. S.
    Agarwal, N.
    Le, T.
    Donskov, F.
    Hansen, A. R.
    Bjarnason, G. A.
    Srinivas, S.
    Wood, L. A.
    Alva, A. S.
    Kanesvaran, R.
    Fu, S. Y. F.
    Davis, I. D.
    Choueiri, T. K.
    Heng, D. Y. C.
    CURRENT ONCOLOGY, 2019, 26 (02) : E175 - E179
  • [46] Baseline levels of proinflammatory cytokines according to body mass index (BMI) and BMI impact on clinical outcomes in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (NIVO) within the NIVOREN trial
    Colomba, E.
    Ajuria, L. Carril
    Dalban, C.
    Derosa, L.
    Silva, C. Alves Costa
    Rassy, E.
    Negrier, S.
    Chevreau, C. M.
    Mescam, G. Gravis
    Oudard, S.
    Laguerre, B.
    Barthelemy, P.
    Goupil, M. Gross
    Geoffrois, L.
    Thiery-Vuillemin, A.
    Lobbedez, F. Joly
    Ladoire, S.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1223 - S1224
  • [47] Cabozantinib in metastatic renal cell carcinoma (mRCC): Real world experience from the UK
    de Liano, Alfonso Gomez
    Venugopal, Balaji
    Fife, Kate
    Khasti, Luma
    Symeonides, Stefan N.
    Pettinger, Claire
    Powles, Thomas
    Rudman, Sarah Maria
    Vasudev, Naveen
    Boleti, Ekaterini
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC).
    Ferrier, Evan
    Lemelin, Audreylie
    Powles, Thomas
    Pal, Sumanta Kumar
    Ebrahimi, Hedyeh
    Agarwal, Neeraj
    Beuselinck, Benoit
    Bjarnason, Georg A.
    Wood, Lori
    Canil, Christina M.
    Saliby, Renee Maria
    de Velasco, Guillermo
    Mckay, Rana R.
    Tran, Ben
    Suarez, Cristina
    Templeton, Arnoud J.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 395 - 395
  • [49] Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study
    Vano, Yann-Alexandre
    Phan, Letuan
    Gravis, Gwenaelle
    Korakis, Iphigenie
    Schlurmann, Friederike
    Maillet, Denis
    Bennamoun, Mostefa
    Houede, Nadine
    Topart, Delphine
    Borchiellini, Delphine
    Barthelemy, Philippe
    Ratta, Raffaele
    Ryckewaert, Thomas
    Hasbini, Ali
    Hans, Sophie
    Emambux, Sheik
    Cournier, Sandra
    Braychenko, Elena
    Elaidi, Reza-Thierry
    Oudard, Stephane
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (08) : 1335 - 1344
  • [50] Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib
    Tomas Buchler
    Marie Kopecka
    Anezka Zemankova
    Markéta Wiesnerová
    Eva Streckova
    Aneta Rozsypalova
    Bohuslav Melichar
    Alexandr Poprach
    Igor Richter
    Targeted Oncology, 2020, 15 : 673 - 679
12345